Suresh R. Giri

Ahmedabad, GJ 382213, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia.

Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia.

Journal: Vaccines
Published: July 02, 2025

Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes.

Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes.

Journal: The Journal of pharmacology and experimental therapeutics
Published: October 29, 2024

Unraveling the Potential Role of Tecomella undulata in Experimental NASH.

Unraveling the Potential Role of Tecomella undulata in Experimental NASH.

Journal: International journal of molecular sciences
Published: January 14, 2023

Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.

Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.

Journal: BMC cancer
Published: July 05, 2022

Needle-free injection system delivery of ZyCoV-D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS-CoV-2.

Needle-free injection system delivery of ZyCoV-D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS-CoV-2.

Journal: Journal of medical virology
Published: July 04, 2022

ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection.

ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection.

Journal: Viruses
Published: September 29, 2021

Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.

Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.

Journal: Bioorganic & medicinal chemistry
Published: December 07, 2020

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease.

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease.

Journal: Scientific reports
Published: November 16, 2019

Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.

Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.

Journal: Bioorganic & medicinal chemistry letters
Published: January 17, 2018

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 21, 2017

Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice.

Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice.

Journal: Journal of pineal research
Published: October 04, 2016

Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist.

Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist.

Journal: ACS medicinal chemistry letters
Published: August 19, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026